REBOA治疗爆炸伤多发伤:猪模型中3区较1区提供脑灌注、减轻器官功能障碍与再灌注凝血病
该研究在50 kg雄性约克夏猪爆炸伤多发伤模型上,随机分为无主动脉阻断(No AO,n=6)、REBOA 1区(AO Zone 1,n=6)和3区(AO Zone 3,n=4),监测240分钟。两阻断组平均动脉压均显著升高;三组颅内压均显著升高,但终末颅内压No AO组(26±5.8 mm Hg)显著高于1区(17±5.2 mm Hg)和3区(16±4.2 mm Hg)(p<0.01)。No AO组终末肌钙蛋白(4.10±5.67 ng/mL)显著高于基线(0.03±0.02 ng/mL,p<0.05),两阻断组无显著变化(p>0.05)。仅1区组出现高纤溶(p<0.05)和凝血酶原时间显著延长(p<0.05),且仅1区组器官损伤标志物显著升高。作者认为3区REBOA可能优于1区,但需进一步临床研究。
要点
- 在50 kg雄性约克夏猪爆炸伤多发伤模型中,REBOA 1区和3区阻断期间平均动脉压均显著升高。
- 终末颅内压No AO组26±5.8 mm Hg,显著高于1区17±5.2 mm Hg和3区16±4.2 mm Hg(p<0.01)。
- 终末肌钙蛋白No AO组4.10±5.67 ng/mL显著高于基线0.03±0.02 ng/mL(p<0.05),两阻断组无显著变化(p>0.05)。
- 仅1区组出现高纤溶(p<0.05)和凝血酶原时间显著延长(p<0.05)。
- 仅1区组器官损伤标志物显著升高;作者认为3区REBOA可能优于1区,但需进一步临床研究。
适用人群与场景
- 50 kg雄性约克夏猪爆炸伤多发伤模型,模拟骨盆/下肢损伤所致严重创伤性出血。
处置流程与药物剂量
- REBOA 1区:主动脉阻断位于腹腔干以上。
- REBOA 3区:主动脉阻断位于肾动脉以下。
- 复苏方案中随机分配至无主动脉阻断(No AO,n=6)、1区阻断(n=6)或3区阻断(n=4),监测生命体征和颅内压240分钟。
研究设计与关键结果
- 研究类型:动物实验(猪爆炸伤多发伤模型),随机分为No AO组(n=6)、REBOA 1区组(n=6)和3区组(n=4),监测240分钟。
- 两阻断组在主动脉阻断期间平均动脉压均显著升高。
- 三组颅内压均显著升高,但终末颅内压No AO组(26±5.8 mm Hg)显著高于1区组(17±5.2 mm Hg)和3区组(16±4.2 mm Hg)(p<0.01)。
- 终末肌钙蛋白No AO组(4.10±5.67 ng/mL)显著高于基线(0.03±0.02 ng/mL,p<0.05),两阻断组无显著变化(p>0.05)。
- 仅1区组出现高纤溶(p<0.05)和凝血酶原时间显著延长(p<0.05)。
- 仅1区组器官损伤标志物显著升高。
证据类型、等级与局限
- 证据类型:动物实验(猪模型)。
- 局限:作者指出需进一步临床研究(further clinical investigation is warranted)。
对床旁实践的改变
- 作者认为,对于军事相关的爆炸伤多发伤且腹腔和胸部创伤轻微者,3区REBOA可能优于1区,但需进一步临床研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a lifesaving therapy for hemorrhagic shock following pelvic/lower extremity injuries in military settings. However, Zone 1 aortic occlusion (AO; above the celiac artery), while providing brain/cardiac perfusion, may induce/worsen visceral ischemia and organ dysfunction. In contrast, AO Zone 3 (below the renal arteries) provides abdominal perfusion potentially minimizing ischemia/reperfusion injury. We hypothesized that, compared with AO Zone 1, AO Zone 3 provides neuro/cardioprotection while minimizing visceral ischemia and reperfusion coagulopathy after severe traumatic hemorrhage due to pelvic/lower extremity injuries.
METHODS: Fifty-kilogram male Yorkshire swine underwent a blast polytrauma injury followed by a resuscitation protocol with randomization to no AO (No AO, n = 6) or AO with REBOA at Zone 1 (AO Zone 1; n = 6) or Zone 3 (AO Zone 3; n = 4). Vital signs and intracranial pressure (ICP) were monitored for 240 minutes. Citrate native and tissue plasminogen activator challenge thrombelastography, prothrombin time, creatinine, lipase, total bilirubin, troponin, and enzyme-linked immunosorbent assays protein levels were measured at set intervals.
RESULTS: Both AO groups had significant increases in mean arterial pressure during aortic occlusion. All three groups had significant increases in ICP, but final ICP in the No AO group (26 ± 5.8 mm Hg) was significantly elevated compared with AO Zone 1 (17 ± 5.2 mm Hg) and AO Zone 3 (16 ± 4.2 mm Hg) ( p < 0.01). The final mean troponin in the No AO group (4.10 ± 5.67 ng/mL) was significantly higher than baseline (0.03 ± 0.02 ng/mL, p < 0.05), while the two AO groups had no significant changes ( p > 0.05). AO Zone 1 was the only group associated with hyperfibrinolysis ( p < 0.05) and significantly increased prothrombin time ( p < 0.05). Only AO Zone 1 group had significantly higher markers of organ damage.
CONCLUSION: Compared with AO Zone 1, AO Zone 3 provided similar neuro/cardioprotection but with less organ dysfunction and coagulopathy. This study suggests that Zone 3 REBOA may be preferable over Zone 1 for treating military relevant blast polytrauma with minimal intra-abdominal and chest trauma, but further clinical investigation is warranted.
参考来源
- Cralley AL, Moore EE, Sauaia A, et al. REBOA for the Treatment of Blast Polytrauma: Zone 3 Provides Cerebral Perfusion, Attenuates Organ Dysfunction and Reperfusion Coagulopathy Compared to Zone 1 in a Swine Model. J Trauma Acute Care Surg. 2023. PMID: 36749658. doi:10.1097/TA.0000000000003894
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。